import 'dart:ui';

const Color appBarColor = Color(0xffC50201);

const String articleDetails = "The year 2023 has seen remarkable medical advances. Among the most notable is the approval of the world's first CRISPR/Cas9 gene-editing therapy, called Casgevy, which targets sickle cell disease. This groundbreaking treatment helps patients produce healthy hemoglobin, addressing the abnormal hemoglobin that causes red blood cells to become hard and crescent-shaped, leading to blockages in blood flow. The U.S. Food and Drug Administration (FDA) greenlit this therapy on December 8, and by March 2024, it will decide whether the same therapy can be used for beta-thalassemia, a disorder that reduces hemoglobin productionhttps://www.sciencenews.org/article/medical-advances-vaccines-drugs-2023.";


